Oncology

Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials
Chun-Jing Geng, Qian Liang, Jian-Hong Zhong, Min Zhu, Fan-Ying Meng, Ning Wu, Rui Liang, Bin-Yi Yuan

BMJ Open Jun 2015, 5 (6) e007258; DOI: 10.1136/bmjopen-2014-007258
How do organisational characteristics influence teamwork and service delivery in lung cancer diagnostic assessment programmes? A mixed-methods study
Gladys N Honein-AbouHaidar, Terri Stuart-McEwan, Tom Waddell, Alexandra Salvarrey, Jennifer Smylie, Mark J Dobrow, Melissa C Brouwers, Anna R Gagliardi

BMJ Open Feb 2017, 7 (2) e013965; DOI: 10.1136/bmjopen-2016-013965
Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer
Jon Emery, Juanita Doorey, Michael Jefford, Madeleine King, Marie Pirotta, Dickon Hayne, Andrew Martin, Lyndal Trevena, Tee Lim, Roger Constable, Cynthia Hawks, Amelia Hyatt, Akhlil Hamid, John Violet, Suki Gill, Mark Frydenberg, Penelope Schofield

BMJ Open Mar 2014, 4 (3) e004972; DOI: 10.1136/bmjopen-2014-004972
The Improving Rural Cancer Outcomes (IRCO) Trial: a factorial cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural patients with cancer in Western Australia: a study protocol
Jon D Emery, Victoria Gray, Fiona M Walter, Shelley Cheetham, Emma J Croager, Terry Slevin, Christobel Saunders, Tim Threlfall, Kirsten Auret, Anna K Nowak, Elizabeth Geelhoed, Max Bulsara, C D'Arcy J Holman

BMJ Open Sep 2014, 4 (9) e006156; DOI: 10.1136/bmjopen-2014-006156
Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
Ulrich Ronellenfitsch, Antonia Dimitrakopoulou-Strauss, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar R Pilz, Ulrike Attenberger, Timo Gaiser, Gerlinde Egerer, Stefan Fröhling, Hans-Günter Derigs, Matthias Schwarzbach, Peter Hohenberger

BMJ Open Jan 2016, 6 (1) e009558; DOI: 10.1136/bmjopen-2015-009558
Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)
Lamiae Grimaldi-Bensouda, Olaf Klungel, Xavier Kurz, Mark C H de Groot, Ana S Maciel Afonso, Marie L de Bruin, Robert Reynolds, Michel Rossignol

BMJ Open Jan 2016, 6 (1) e009147; DOI: 10.1136/bmjopen-2015-009147
Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials
Martin H N Tattersall, Michael Jefford, Andrew Martin, Ian Olver, John F Thompson, Richard F Brown, Phyllis N Butow

BMJ Open Mar 2017, 7 (3) e012666; DOI: 10.1136/bmjopen-2016-012666
Cancer Data and Aboriginal Disparities (CanDAD)—developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol
Paul Henry Yerrell, David Roder, Margaret Cargo, Rachel Reilly, David Banham, Jasmine May Micklem, Kim Morey, Harold Bundamurra Stewart, Janet Stajic, Michael Norris, Alex Brown

BMJ Open Dec 2016, 6 (12) e012505; DOI: 10.1136/bmjopen-2016-012505
Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials
Zhi-qiao Xu, Yan Zhang, Ning Li, Pei-jie Liu, Ling Gao, Xin Gao, Xiao-jing Tie

BMJ Open Mar 2017, 7 (3) e013053; DOI: 10.1136/bmjopen-2016-013053
The mortality and cancer experience of New Zealand Vietnam war veterans: a cohort study
David McBride, Brian Cox, John Broughton, Darryl Tong

BMJ Open Aug 2013, 3 (9) e003379; DOI: 10.1136/bmjopen-2013-003379

Main menu

Oncology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Oncology

Pages